Literature DB >> 33230518

Assessment of long-term outcomes: aortic valve reimplantation versus aortic valve and root replacement with biological valved conduit in aortic root aneurysm with tricuspid valve.

Tsuyoshi Yamabe1,2, Yanling Zhao1, Paul A Kurlansky1, Suzuka Nitta1, Michael A Borger3, Isaac George1, Craig R Smith1, Hiroo Takayama1.   

Abstract

OBJECTIVES: We compared the long-term outcomes between aortic valve reimplantation [David V (DV)] and aortic valve and root replacement with biological valved conduit [Bentall-De Bono (BD)] for the patients with aortic root aneurysm with tricuspid valve.
METHODS: Among 876 patients who underwent aortic root replacement in our institution between 2005 and 2018, 371 patients who underwent DV (n = 199) or BD (n = 172) for aortic root aneurysm with tricuspid valve were retrospectively reviewed. Exclusion criteria included aortic stenosis, infective endocarditis, previous prosthetic aortic valve, bicuspid aortic valve, aortic dissection and mechanical Bentall procedure. Propensity score matching was performed based on the patient characteristics, matching 90 patients in each group. The primary end point was all-cause mortality. Secondary end points were reoperation for any cause and specifically for aortic valve-related cause.
RESULTS: After propensity score matching, DV and BD groups each had 1 in-hospital mortality (1.1%). Survival at 10 years was 95.3% [95% confidence interval (CI) 85.8-98.5] in DV and 98.6% (95% CI 90.8-99.8) in BD (P = 0.345). The cumulative incidences of reoperation at 10 years in DV versus BD were 3.9% (95% CI 0.7-11.8) vs 18.1% (95% CI 6.9-33.4) for any cause (P = 0.046) and 1.9% (95% CI 0.1-8.8) vs 15.9% (95% CI 5.5-31.4) for aortic valve-related causes (P = 0.032). The reasons for valve-related reoperation were aortic insufficiency (3/5 in DV vs 5/10 in BD), aortic stenosis (0/5 vs 2/10) and infective endocarditis (2/5 vs 3/10).
CONCLUSIONS: Both DV and BD procedures for patients with aortic root aneurysm with tricuspid valve resulted in excellent 10-year survival. All-cause and aortic valve-related reoperations were significantly less frequent with valve-sparing root replacement, suggesting an advantage of DV over biological BD.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Aortic root aneurysm; Aortic root replacement; Aortic valve reimplantation; Biological valved conduit; Long-term outcomes; Valve-sparing aortic root replacement

Year:  2021        PMID: 33230518     DOI: 10.1093/ejcts/ezaa389

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  A novel dosing strategy of del Nido cardioplegia in aortic surgery.

Authors:  Megan M Chung; William C Erwin; Yuming Ning; Yanling Zhao; Christine Chan; Alex D'Angelo; Alexander Kossar; Jessica Spellman; Paul Kurlansky; Hiroo Takayama
Journal:  JTCVS Open       Date:  2022-04-23

2.  Aortic root replacement in bicuspid versus tricuspid aortic valve patients.

Authors:  Josephina Haunschild; Zara Dietze; Antonia van Kampen; Khadzhimurad Magomedov; Martin Misfeld; Sergey Leontyev; Michael A Borger; Christian D Etz
Journal:  Ann Cardiothorac Surg       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.